drugset / Trial / NCT00002239
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
Treatment
Summary
The purpose of this study is to see if it is safe and effective to give T-20, a new type of anti-HIV drug, with a combination of other anti-HIV drugs. The other anti-HIV drugs used are abacavir (ABC), amprenavir (APV), ritonavir (RTV), and efavirenz (EFV). Three different doses of T-20 are tested.
Timeline
- Start
- 1999-05
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | — | Oral |
| Subject | Amprenavir | Other / unclassified | — | Oral |
| Subject | Efavirenz | Other / unclassified | — | Oral |
| Subject | Enfuvirtide | Peptide | — | — |
| Subject | Ritonavir | Other / unclassified | — | Oral |